Andrew Lo, Ph.D.
DirectoratBridgeBio Pharma· In proxies 2022–2025
Andrew Lo, Ph.D. sits on 6 public boards.
Experience
- BridgeBio PharmaPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +938%
- AbCellera BiologicsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Roivant SciencesPublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Atomwise Inc.Public company
- Director? – PresentNo stock prices for these years
- Uncommon CuresPublic company
- Director? – PresentNo stock prices for these years
- Vesalius TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- AbCellera Biologics Inc.Public company · 4 yr
- Director2021 – 2025 · 4 yrNo stock prices for these years
%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?